Down-regulation of High Mobility Group-I(Y) Protein Contributes to the Inhibition of Nitric-oxide Synthase 2 by Transforming Growth Factor-β1
Andrea Pellacani(Harvard University), Mark A. Perrella(Brigham and Women's Hospital), Vedrana Vasilj, Raymond Reeves(Washington State University), Susan Razavi, Michael T. Chin(Tufts Medical Center), Philippe Wiesel(Harvard University), Mark W. Feinberg(Brigham and Women's Hospital)
Cited by 38
Related Papers
Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis.
|Proceedings of the National Academy of Sciences|1994|806
Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life.
|Circulation Research|1993|776
Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP.
|Proceedings of the National Academy of Sciences|1995|710
MicroRNA Regulation of Atherosclerosis
|Circulation Research|2016|629
Natriuretic peptide system in human heart failure.
|Circulation|1993|461